Western Standard LLC Abeona Therapeutics Inc. Transaction History
Western Standard LLC
- $180 Million
- Q2 2025
A detailed history of Western Standard LLC transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Western Standard LLC holds 2,091,598 shares of ABEO stock, worth $13.3 Million. This represents 6.61% of its overall portfolio holdings.
Number of Shares
2,091,598
Previous 2,281,199
8.31%
Holding current value
$13.3 Million
Previous $10.9 Million
9.41%
% of portfolio
6.61%
Previous 6.48%
Shares
8 transactions
Others Institutions Holding ABEO
# of Institutions
102Shares Held
31.6MCall Options Held
2.42MPut Options Held
212K-
Nantahala Capital Management, LLC New Canaan, CT4.37MShares$27.9 Million1.08% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.07MShares$19.6 Million0.03% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.68MShares$17.1 Million0.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.51MShares$16 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.84MShares$11.8 Million2.22% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $38M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...